Nova Patents
ATE64304T1

Method of conferring immunotolerance to a specific antigen

Abstract

A method of selectively suppressing the immune system and conferring immunotolerance against a specific antigen by interferring with the L3T4 differentiation antigens on helper T cells is described. Simultaneous administration of a binding moiety specific for the L3T4-equivalent in the subject species and a specific antigen results in a diminished ability of the subject to respond immunologically to the antigen, whether or not the subject has been exposed previously to the antigen.

Term

Term ended

Projected expiry passed 15 April 2006, 20.4 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

11 members in 6 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
72406385United States of AmericaA

Members11

Family members, oldest first
DocumentOfficeKind
EP0200412A2European Patent Office (EPO)A2
JPS6236AJapanA
US4681760AUnited States of AmericaA
EP0200412A3European Patent Office (EPO)A3
CA1266232ACanadaA
US4904481AUnited States of AmericaA
EP0200412B1European Patent Office (EPO)B1
AT64304TAustriaT
ATE64304T1This recordAustriaT1
DE3679708D1GermanyD1
JP2530316B2JapanB2